Login / Signup

Assessing the diagnostic performance of new commercial IGRAs for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

Edgar Ortiz-BrizuelaLika AprianiTania MukherjeeSophie Lachapelle-ChisholmMichele MiedyZhiyi LanAlexei KorobitsynNazir IsmailDick Menzies
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
The QFT-plus and the TB-IGRA have very similar sensitivity and specificity as WHO-approved IGRAs.
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • drug administration
  • structural basis